abstract |
The present invention is for use in the treatment or prevention of reperfusion injury, such as ischemic reperfusion injury, by inhibiting the accumulation of succinic acid, a cell permeable reversible inhibitor of succinate dehydrogenase. It relates to a succinate dehydrogenase inhibitor or prodrug and / or a pharmaceutically acceptable salt thereof. |